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BALB/cCrgl mice are characterized by a low incidence of spontaneous mam- 
mary tumors (SMT). Exogenous mouse mammary tumor virus (MMTV) is not 
found in this murine strain: However, these mice contain one subgenomic-size 
and two genomic-size MMTV proviruses (1). As previously reported (2), we have 
developed a colony of immunodeficient  BALB/c mice by mating asplenic females 
with nude males that have been reconstituted with a congenic thymocyte intra- 
peritoneal suspension equivalent to half a normal thymus. With these crossings, 
we have produced female breeders heterozygous for both nude and asplenia 
traits.  Here,  we present evidence indicating that the heterozygous nude trait 
increases the incidence of SMT. Furthermore, the simultaneous presence of the 
nude gene and the asplenia trait results in a  very high percentage of SMT in 
BALB/c female breeders. Restriction endonuclease patterns of the liver DNA 
from normal and immunodeficient mice appear to be identical, with respect to 
the MMTV provirus copy number and organization. These results suggest that 
the increased tumorigenicity observed is due to a  synergistic action of spleen 
agenesis with the heterozygous nude condition, during the latency period or at 
the host immune level. 
Materials and Methods 
Mice.  The description of the development of the nude and asplenic colonies has been 
previously reported (2).  The maintenance of the combined asplenia and heterozygous 
nude genes in BALB/c mice is accomplished by breeding nu/nu males with the asplenic 
females heterozygous for both the Dh and nu genes (nu[+, Dh/+). The progeny of such 
matings produces BALB/c offspring with four different phenotypes segregating equally 
among: nu/+ and +/+, of normal phenotype; nu/+ and Dh[+, characterized by a white 
coat, skeletal anomalies of the  hind  limbs, and spleen agenesis; nu/nu and  +/+,  nude 
(hairless) athymic; and nu/nu and Dh/+, the lasat mouse, with the combined characteristics 
of athymia, asplenia, hairlessness, and anomalous hind legs. 
The BALB/c background of the various genotypes discussed above has been ascertained 
by grafting experiments.  Skin  grafts from mice of +/+,  Dh/+; nu/+, +/+;  or nu/+, 
Dh/+ genotypes were implanted in  2-mo-old BALB/c mice of +/+,  +/+ background. 
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The transplanted mice did not reject the skin grafts, indicating  that the genetic makeup 
of the immunodeficient mice is BALB/c. 
Nucleic Acid Isolation, Restriction Endonuclease Digestion, and Southern Blotting.  DNA 
isolation,  restriction  endonuclease digestion,  agarose  gel  electrophoresis,  nucleic  acid 
transfer to nitrocellulose,  and filter hybridization  was performed as previously described 
(3). a-[3~P]-labeled MMTV DNA complementary to 70 S MMTV RNA was prepared as 
previously reported (4). 
Results 
Female nu/+, Dh/+ breeder  BALB/c mice develop a  high  number of SMT 
from an early age. On initial detection, tumors are ~0.5 cm in diameter.  They 
grow rapidly, causing death within 30-45 d. We began a study to compare the 
relative  incidences  of SMT  in  a  large  number  of  BALB/c  mice  of various 
genotypes relating  to the nu and Dh genes. Table  I  summarizes  the results of 
these analyses.  Of 492  normal  BALB/c breeders in our colony, only four ani- 
mals  developed SMT.  Introduction  of the  heterozygous Dh  gene  in  BALB/c 
mice resulted in a small increase of the overall SMT incidence. BALB/c breeders 
heterozygous for the nu gene had a greater number of SMT before 19 too. This 
incidence  (23.8%)  is  significantly  (P  <0.01)  higher  than  that  of the  parent 
BALB/c strain without the nude gene (0.8%), or with the heterozygous Dh gene 
(5.8%). The asplenic female breeders of genotype nu/+, Dh/+ have the highest 
incidence of SMT (57.9%) before 19 mo of age. SMT were observed in neither 
nu/+, +/+ nor in nu/+, Dh/+ female virgins up to 16 mo of age. The generally 
shorter lifespan and difficulty of breeding female mice homozygous for the nu 
gene has precluded an adequate comparison of the SMT incidence in BALB/c 
of the nu/nu, +/+ genotype. Likewise, the nu/nu, Dh/+ (lasat) mice live only for 
3-4 mo, and are not capable of successful matings. 
The age distribution and percentages of SMT are presented in Fig.  1. Immu- 
nodeficient  BALB/c breeders (nu/+, Dh/+) develop SMT as early as 5  mo of 
age. The maximum incidence occurred between 14 and  19 mo, but high levels 
of SMT were observed as early as 10 mo of age (21%). Very few BALB/c of the 
nu/+,  +/+  genotype  developed  tumors  during  the  first  15  mo  (0.2-6.1%). 
However,  at  19  mo,  an  incidence  of  30.6%  could  be  observed  within  the 
remaining  101  breeders of the original  507 experimental  animals.  These mice 
usually had one mammary tumor, while the nu/+, Dh/+ siblings often had from 
two to four SMT. 
The germinally-transmittedMMTV  proviral DNA was analyzed by restriction 
endonuclease mapping to determine if the BALB/c immunodeficient mice have 
TABLE  I 
Incidence of SMT in Inbred BALB/c Mice 
BALB/c  Age at tumor  Total num-  Mice with  Overall inci- 
genotype  appearance  ber of mice  SMT  dence of SMT 
mo  % 
+/+, +/+  __.20  492  4  0.8 
+/+, Dh/+*  _<17  137  8  5.8 
nu/+*, +/+  5-19  507  133  23.8 
nu/+, Dh/+  5-19  615  351  57.9 
* Dh/+: heterozygous for dominant hemimelia. 
* nu/+:  heterozygous for athymia. LOPEZ ET  AL.  BRIEF  DEFINITIVE REPORT  631 
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FIGURE  1.  Comparison  of the incidence and age distribution of SMT in BALB/c mice 
heterozygous  for the nude gene (nu/+, +/+) (1), with that of mice heterozygous  for both the 
nu and Dh genes (nu/+, Dh/+) (m). The total number of mice of the nu/+, Dh/+ genotype  is 
shown on the top of each column as the numerator, while the total number of mice of the 
nu/+, +/+ genotype  is shown as the denominator. 
a germ line complement of MMTV DNA identical to the characteristic BALB/c 
complement (1), or if they are characterized by an additional or altered MMTV 
germline complement. In addition, since the immunodeficient genotypes, nu and 
Dh, had been crossed into BALB/c mice from strain backgrounds that included 
C3H/He,  C57BL/10J,  and  CBA/CaJ,  MMTV  maps  from  these  strains  are 
included for comparison.  BALB/cCrgl, C3H/HeJ,  C57BL/10J, and CBA/CaJ 
liver DNA were digested with Eco RI, Barn HI, or Pst I, and restriction fragments 
containing MMTV DNA were identified by molecular hybridization with an a- 
[32p]-probe  complementary to 70  S  MMTV  RNA (4,  and Fig. 2).  The results 
demonstrate that  MMTV sequences in  BALB/c DNA are  distinguished from 
C3H/HeJ and C57BL/10J by Eco RI  (Fig.  2)  and Hind III (data not shown) 
digestions, and from CBA/CaJ by Eco RI and Pst I  digestions (Fig.  2).  Using 
these enzymes, at least two unique-size MMTV DNA fragments can distinguish 
between BALB/c DNA and MMTV sequences present in C3H/HeJ, C57BL/10J, 
and CBA/CaJ genomes. Restriction digestions with Eco RI, Bam HI, Pst I (Fig. 
2),  and  Hind  III  (data  not  shown) demonstrated an  identical complement of 
MMTV sequences between BALB/cCrgl DNA (Fig. 2,  lanes 1,6,  and I1) and 
liver DNA of a nu/+, Dh/+ mouse (Fig. 2, lanes 5, 10, and 15). Therefore, the 
immunodeficient BALB/c nu/+, Dh/+ strain, as well as the nu/+, +/+; nu/nu, 
+/+;  +/+,  Dh/+,  and nu/nu,  Dh/+  (data  not  shown)  genotypes contained a 
germline complement of MMTV DNA identical to the BALB/cCrgl +/+, +/+ 
strain,  which has a  low  incidence of mammary tumors.  That  is,  all  of these 
immunodeficient BALB/c mice contain a subgenomic MMTV provirus, Unit I 
or mtv-6, and two genomic MMTV proviruses, Units II and III, or mtv-8 and 
mtv-9, respectively (1),  that have previously (3,  5) been characterized in detail 
by restriction  mapping, and  molecular hybridization with cloned subgenomic 632  LOPEZ  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIGLrRE 2.  MMTV  proviral  DNA  in  inbred and  immunodeficient mouse  strains.  Total 
cellular DNA was isolated from liver nuclei of 2-mo-old BALB/cCrgl (lanes 1, 6, and 11), 
C3H/HeJ (lanes 2, 7, and 12), C57BL/10J (lanes 3, 8, and 13), CBA/CaJ (lanes 4, 9, and 14), 
and BALB/c nu/nu, Dh/+ mice (lanes 5,  10,  and 15).  10 #g of DNA were digested with 
Eco RI, lanes 1-5; Barn HI, lanes 6-10; or Pst I, lanes 11-15. Following electrophoresis and 
transfer, the filter was hybridized with a-lSSp]MMTV-complementary  DNA. Autoradiography 
was for 27 h.  Phage "r DNA digested with Hind III produced molecular weight references, 
indicated in the left margin, of 21.8, 9.5, 6.8, 4.3, 2.3, 2.0, and 0.6 kbasepairs. 
MMTV probes.  Importantly,  these data demonstrate  that mammary tumors in 
the immunodeficient BALB/c mice cannot be due to the presence of the C3Hf 
MMTV Unit V (mtv-1), which is responsible for late mammary tumors in C3Hf 
strains (6, 7). 
Discussion 
Our  studies  demonstrate  that  the  coexistence  of the  nu  and  Dh  genes  in 
heterozygous form in female breeders of the BALB/c strain  is associated with 
an  early and  dramatic  increase  in  the  incidence  of SMT.  No such  increase  in 
SMT could be observed in animals heterozygous for the Dh gene alone. However, 
a higher rate of SMT can be detected in female BALB/c breeders heterozygous 
for the nude gene.  This is the first demonstration  that  the nu/+ genotype, as 
opposed  to  the  nu/nu  genotype,  has  any  important  effect on  the  host.  This 
finding suggests the necessity for caution in interpreting  experiments in which 
nu/+ mice serve as controls for an experimental nu/nu group. 
A possible reason for the susceptibility of these mice to mammary tumorigen- 
esis could be genomic acquisition of a provirus from an exogenous source. The LOPEZ  ET  AL.  BRIEF  DEFINITIVE  REPORT  633 
origin of our BALB/c  immunodeficient mice includes the C3H  background, 
where a  mutation for dominant hemimelia was discovered by Searle (8) among 
a  breeding stock of luxate mice. The Dh mutant is inherited as an autosomai 
dominant trait  characterized by abnormalities that  include skeletal anomalies 
(mainly of the hind limbs), and visceral alterations, in addition to splenic agenesis. 
Visceral defects in homozygous (Dh/Dh) mice result in death within a few days 
of birth. Asplenic BALB/c mice were developed by mating female Fx hybrids of 
C57BL/6J-A w'j (Dh/+) female x  CBA/Ca (+/+) male for 10 generations. These 
animals  are  designated  B6CBAFI-Dh  (N10).  The  nude  gene,  discovered  by 
Flanagan in  1966 (9),  is inherited as an autosomal recessive gene and is charac- 
terized by congenital athymia in homozygous mice (10). The mice from which 
our colony originated were maintained on a  BALB/c background for several 
generations. Thus, the origin of our immunodeficient mice includes, in addition 
to the BALB/c genotype, the possible proviral contributions from the low-SMT- 
incidence C57BL/10J and CBA/CaJ strains, and from the high-SMT-incidence 
C3H/H3  strain.  However, the results of our restriction endonuclease MMTV 
mapping showed unequivocally that the germline MMTV sequences in all four 
classes of immunodeficient mice is identical to that of the BALB/c strain, and 
therefore rule out the possibility of perpetuation of an extra MMTV provirus 
that may have been acquired during the development of our animal colony. 
Our studies suggest that the nu gene, in the heterozygous state, may influence 
mammary tumorigenesis in BALB/c mice, by shortening the latency period of 
oncogenesis, or by some other mechanism, such as altering the host immune 
response against the tumor. If the latter is the case, the observed effects may 
have a bearing in the controversial issue of "immune surveillance." Most inves- 
tigators who have analyzed the incidence of spontaneous tumors in nude mice 
have used animals in which the nude gene has been backcrossed to the desired 
background only two or three times. According to Festing (11), five backcrosses 
are required in order to obtain a coefficient of inbreeding of >95%. Our nude 
mouse  colony has  had  more  than  20  generations of inbreeding.  Therefore, 
effects of other loci on the SMT of nu/+, +/+ are unlikely. In addition, a high 
incidence of SMT in nu/+, +/+ mice are observed in female breeders up to 19 
mo of age, which is consistent with the requirement for hormonally regulated 
mammary gland development and differentiation for mammary tumorigenesis. 
The Dh gene per se has only a  modest effect on the overall incidence of SMT. 
However, it appears that the lack of spleen results in a syngergistic action with 
the  heterozygous nude gene on  SMT  incidence in  the BALB/c strain.  Since 
spleen agenesis has been associated with alterations of the immune system, we 
hypothesize that the role of the Dh gene in our model system is one of amplifi- 
cation of the effect of the nu/+ genotype, at the level of host-tumor interactions. 
Summary 
The  BAI.B/c  mouse strain  has  been  shown  to  contain  endogenous mouse 
mamnlary tumor virus  (MMTV) proviral  sequences.  However, no exogenous 
MMTV particles have been detected in their tissues. Female BALB/c mice from 
our  colonies  exhibit  a  very  low  incidence of spontaneous  mammary tumors 
(SMT); <i % at up to 20 mo of  age. Immunodeficient BALB/c mice heterozygous 634  LOPEZ  ET  AL.  BRIEF  DEFINITIVE  REPORT 
for the  nude  gene  (nu/+,  +/+),  for the  dominant  hemimelia  gene  associated 
with asplenia (+/+, Dh/+), or for both traits (nu/+, Dh/+) have been examined 
for SMT incidence and the presence of MMTV proviruses. Based on restriction 
digestion with Eco RI,  Barn HI, and  Pst  I,  the immunodeficient mice have an 
MMTV  provirus copy number and  organization  identical to the  BALB/cCrgl 
strain.  This  MMTV  DNA  pattern  is  distinct  from  the  MMTV  proviruses  in 
C3H/He,  C57BL/6J  and  CBA/CaJ  mice,  which  were  parental  strains  of the 
immunodeficient mutants. Normal female BALB/c or BALB]c heterozygous for 
the asplenic trait do not develop significant numbers of SMT at up to 19 mo of 
age. tn contrast, an incidence of 23.8% and 57.7% SMT was observed in BALB/ 
c nu/+  heterozygotes, and in BALB]c nu/+,  Dh/+  heterozygotes, respectively. 
These results indicate that agenesis of the spleen, concomitant with the presence 
of the heterozygous nude gene, contribute to a  high  incidence of SMT in  the 
Iow-SMT BALB/c mouse strain. 
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